Company: SISI
Filing Date: 2025-03-20
Form Type: 8-K
Source: 0001493152-25-011015
Chunk: 0

Company: SHINECO, INC.
Filing Date: 2025-03-20
Form: 8-K
Item: Item 1.01
Chunk 0
---
Item
1.01 Entry into a Material Definitive Agreement.

On
March 20, 2025, Shineco Life Science Group Hong Kong Co., Limited (“ Shineco Life Science”), a subsidiary of Shineco, Inc.
(the “ Company”), entered into a stock purchase agreement (the “ SPA”) with Yi Yang, a current and only shareholder
of FuWang (HK) International Company Limited (the “ Seller”). Pursuant to the SPA, the Seller shall sell 75% of the equity
interests in FuWang (HK) International Company Limited, a company limited by shares incorporated in Hong Kong (“ FuWang (HK)”),
he holds (the “ FuWang Shares”) to Shineco Life Science. In consideration of the sale of the FuWang Shares, Shineco Life Science
shall pay the Seller RMB 63.89 million in cash (the “ Cash”), the Company shall issue and transfer 3,400,000 shares of the
Company’s common stock, par value $0.001 per share (the “ Shares”) to the Seller and the Company shall transfer the
71.42% equity interests in Dream Partner Limited it holds (the “ Dream Partner Shares”) to the Seller, subject to the terms
and conditions set forth therein. Each of the SPA, the transaction contemplated thereby, the issuance of the Shares, and the transfer
of the Dream Partner Shares has been approved by the Company’s board of directors.

As
of the date hereof, the Cash has not been paid, and the Shares, the FuWang Shares and the Dream Partner Shares have not yet been transferred.
Pursuant to the SPA, the Seller agreed to transfer the FuWang Shares to Shineco Life Science within 10 days after the execution of the
SPA; Shineco Life Science agreed to pay the Seller the Cash within 20 days after the transfer of the FuWang Shares is completed (the
“ Closing”) and the Company shall issue and transfer the Shares and transfer the Dream Partner Shares to the Seller within
30 and 20 days, respectively, after the Closing. The SPA contains other customary obligations and rights of the parties.

The
foregoing description of the SPA is qualified in its entirety by reference to the full text of the Stock Purchase Agreement, which is
filed as Exhibit 10.1 to this Form 8-K and is incorporated herein by reference.

Item
9.01 Financial Statements and Exhibits